ATS 2024 Final Program

Click on the session title to view the speakers

SUNDAY • MAY 19

93

ATS, AARC, ERS MID-DAY SESSION

NHLBI, NIH MID-DAY SESSION

MD6 CURRENT STATE OF PATIENT-VENTILATOR

MD7 THE MOLECULAR ATLAS OF LUNG DEVELOPMENT (LUNGMAP), PHASE 2 12:00 p.m. - 1:00 p.m. San Diego Convention Center Room 28A-B (Upper Level) Target Audience Providers of lung health, medical fellows in training, and basic and clinical researchers interested in lung biology, developmental biology, pediatric lung disease, multi-omics, bioinformatics, and systems biology Objectives At the conclusion of this session, the participant will be able to: • learn the newest datasets of LungMAP that could inform lung research • learn the innovative technologies for molecular profiling, imaging, and data analysis of the developing lung. • learn how to access and use the LungMAP resources. Molecular Atlas of Lung Development (LungMAP) is an NHLBI-sponsored program. The overall goal of this program is to establish an open-access reference resource by creating a comprehensive molecular atlas of the late-stage developing human lung with data and reagents available to the research community. Speakers will demonstrate how developmental biology, multi-omics technologies, and bioinformatic approaches can be used to inform processes in development that are recapitulated in disease and repair. The session will illustrate the LungMAP data pipeline which integrates high resolution multi-omics and imaging data. 12:00 Single-Cell Mapping of Bronchopulmonary Dysplasia 12:12 Multi-Omics Analyses of the Developing Lung in Health and Disease 12:24 Revealing Endothelial Subtypes in Pulmonary Versus Systemic Circulation 12:36 Exploring Spatial Heterogeneity in Chronic Lung Disease 12:48 History and Future of the LungMAP BRINDL Biorepository to Advance Human Lung Research

INTERACTIONS: NOMENCLATURE, RESEARCH, AND OUTCOME

12:00 p.m. - 1:00 p.m.

San Diego Convention Center Room 7A-B (Upper Level)

Target Audience Clinical Science Translational Clinicians Data Scientists All attendees Biomedical Engineers Medical Educators Nurses Objectives At the conclusion of this session, the participant will be able to: • diagnose the presence of mechanical ventilator-patient discordance. The learner will recognize the patterns and will be able to highlight differences in nomenclature leading to improved patient care and outcomes. • have new targets to implement research regarding patient-ventilator interactions and recognize best practices when quantifying them. • learn the current state of the field of patient ventilator interactions and how these affect patient outcomes. Critical Care providers must be knowledgeable in patient-ventilator interactions as this has implications in patient experience and outcomes. Although there is a large amount of literature published on the topic, there is discrepancy in nomenclature, methods to measure and quantify and how we define outcomes. This session will highlight current knowledge and discuss future research strategies and organization to promote homogeneity in nomenclature and to define meaningful end-point parameters to be used in such clinical research on interventions to reduce ventilator-patient discordances. A joint session amongst the leading societies in critical care and respiratory care will help pave the way for a unified statement. 12:00 The Current State of Nomenclature in Patient-Ventilator Interactions 12:15 How Do We Define and Measure Synchrony 12:27 Linking Patient-Ventilator Discordances to Patient Outcomes 12:39 Current areas of clinical uncertainty and research direct in Patient-ventilation Interactions 12:53 Questions and Discussions for Presenters

ATS 2024 Conference Program • San Diego, CA